TRIAZINE COMPOUNDS AS P13 KINASE AND MTOR INHIBITORS

TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS Compounds of formula I wherein: R 1 is and R 2 , R 4 , and R 6-9 are defined herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit PI3 kinase and mTOR, and may be used to treat diseases mediated by PI3 kinase an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: AYRAL-KALOUSTIAN, Semiramis, DEHNHARDT, Christoph M, DOS SANTOS, Osvaldo, CHEN, Zecheng, ZASK, Arie, KAPLAN, Joshua Aaron, VENKATESAN, Aranapakam M, DELOS SANTOS, Efren Guillermo, GOPALSAMY, Ariamala, CURRAN, Kevin J, VERHEIJEN, Jeroen C, RICHARD, David J, MANSOUR, Tarek S, SHI, Mengxiao
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS Compounds of formula I wherein: R 1 is and R 2 , R 4 , and R 6-9 are defined herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit PI3 kinase and mTOR, and may be used to treat diseases mediated by PI3 kinase and mTOR, such as a variety of cancers. Methods for making and using the compounds of this invention are disclosed. Various compositions containing the compounds of this invention are also disclosed.